↓ Skip to main content

Cochrane Database of Systematic Reviews

Sumatriptan (intranasal route of administration) for acute migraine attacks in adults

Overview of attention for article published in Cochrane database of systematic reviews, February 2012
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (51st percentile)

Mentioned by

twitter
4 tweeters

Citations

dimensions_citation
39 Dimensions

Readers on

mendeley
105 Mendeley
Title
Sumatriptan (intranasal route of administration) for acute migraine attacks in adults
Published in
Cochrane database of systematic reviews, February 2012
DOI 10.1002/14651858.cd009663
Pubmed ID
Authors

Christopher J Derry, Sheena Derry, R Andrew Moore

Abstract

Migraine is a highly disabling condition for the individual and also has wide-reaching implications for society, healthcare services, and the economy. Sumatriptan is an abortive medication for migraine attacks, belonging to the triptan family. Intranasal administration may be preferable to oral for individuals experiencing nausea and/or vomiting, although it is primarily absorbed in the gut, not the nasal mucosa.

Twitter Demographics

The data shown below were collected from the profiles of 4 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 105 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 <1%
Russia 1 <1%
Unknown 103 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 21 20%
Student > Doctoral Student 11 10%
Student > Ph. D. Student 10 10%
Student > Bachelor 9 9%
Researcher 8 8%
Other 21 20%
Unknown 25 24%
Readers by discipline Count As %
Medicine and Dentistry 35 33%
Pharmacology, Toxicology and Pharmaceutical Science 10 10%
Nursing and Health Professions 9 9%
Psychology 8 8%
Neuroscience 4 4%
Other 13 12%
Unknown 26 25%

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 September 2019.
All research outputs
#8,445,181
of 15,791,413 outputs
Outputs from Cochrane database of systematic reviews
#8,665
of 11,290 outputs
Outputs of similar age
#60,184
of 125,211 outputs
Outputs of similar age from Cochrane database of systematic reviews
#86
of 123 outputs
Altmetric has tracked 15,791,413 research outputs across all sources so far. This one is in the 46th percentile – i.e., 46% of other outputs scored the same or lower than it.
So far Altmetric has tracked 11,290 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 23.4. This one is in the 22nd percentile – i.e., 22% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 125,211 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 51% of its contemporaries.
We're also able to compare this research output to 123 others from the same source and published within six weeks on either side of this one. This one is in the 29th percentile – i.e., 29% of its contemporaries scored the same or lower than it.